CPIG
TIL icon

Chicago Partners Investment Group’s Instil Bio TIL Stock Holding History

Chicago Partners Investment Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,007
Closed -$18.2K – 688
2022
Q4 		$18.2K Buy
+1,007
New +$49.8K ﹤0.01% 637

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Chicago Partners Investment Group's TIL Position: Q1 2023 in Review

Chicago Partners Investment Group sold out of Instil Bio (TIL) in Q1 2023, closing a stake of 1,007 shares — an estimated $18.2K sold.

Chicago Partners Investment Group first reported a position in TIL in Q4 2022 and held it in 1 quarter. The position peaked at $18.2K in Q4 2022. 73 funds tracked by Wall St. Rank hold TIL as of Q1 2023.

  • Chicago Partners Investment Group reported no remaining Instil Bio position as of Q1 2023 after selling out during the quarter.
  • Chicago Partners Investment Group sold 1,007 Instil Bio shares in Q1 2023, an estimated $18.2K.
  • Chicago Partners Investment Group first reported a position in Instil Bio in Q4 2022 and held it in 1 quarter.
  • Chicago Partners Investment Group's Instil Bio position peaked at $18.2K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held Instil Bio as of Q1 2023.

Based on Chicago Partners Investment Group's 13F filing for Q1 2023, filed 26 Apr 2023.